Have you been able to find a good deal on Chemours Company’s shares?

While Chemours Company has underperformed by -0.16%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CC fell by -44.49%, with highs and lows ranging from $34.51 to $15.10, whereas the simple moving average fell by -29.31% in the last 200 days.

On July 09, 2024, UBS Upgraded Chemours Company (NYSE: CC) to Buy. A report published by Mizuho on June 07, 2024, Initiated its previous ‘Neutral’ rating for CC. BMO Capital Markets also Upgraded CC shares as ‘Outperform’, setting a target price of $34 on the company’s shares in a report dated April 09, 2024. UBS March 05, 2024d the rating to Neutral on March 05, 2024, and set its price target from $37 to $21. BMO Capital Markets February 29, 2024d its ‘Outperform’ rating to ‘Underperform’ for CC, as published in its report on February 29, 2024. RBC Capital Mkts’s report from December 01, 2023 suggests a price prediction of $40 for CC shares, giving the stock a ‘Outperform’ rating. BofA Securities also rated the stock as ‘Neutral’.

Analysis of Chemours Company (CC)

With CC’s current dividend of $1.00 per share, investors can expect to earn a return regardless of performance. Further, the quarter-over-quarter decrease in sales is -6.39%, showing a negative trend in the upcoming months.

Chemours Company’s future performance can be determined with the help of several well-rounded types of analysis and research techniques, with equity being one of the most influential. The goal here is to ensure that your current return on equity of 15.15% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 1.01, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.

The average volume for any stock is also a very valuable indicator of volatility, and CC has an average volume of 1.38M. On a monthly basis, the volatility of the stock is set at 3.12%, whereas on a weekly basis, it is put at 2.95%, with a loss of -2.58% over the past seven days. Furthermore, long-term investors anticipate a median target price of $26.60, showing growth from the present price of $18.50, which can serve as yet another indication of whether CC is worth investing in or should be passed over.

How Do You Analyze Chemours Company Shares?

Specialty Chemicals giant Chemours Company (CC) is based in the USA and is one of the largest companies in the market. When comparing Chemours Company shares with other companies under Basic Materials, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 23.99, there is a growth in quarterly earnings of 118.49%.

In addition to analyzing the fundamentals, it is also important to look at how many company employees own stock. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 1.34%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 79.17% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.

CC shares are owned by institutional investors to the tune of 79.17% at present.